Pre-treatment by omalizumab allows allergen immunotherapy in children and young adults with severe allergic asthma

被引：39

作者：

Lambert, Nathalie ^{[1
,2
]}

Guiddir, Tamazoust ^{[1
,2
]}

Amat, Flore ^{[1
,2
]}

Just, Jocelyne ^{[1
,2
]}

机构：

[1] Hop Enfants, Ctr Asthme & Allergies, Dept Allergol, Paris 12, France

[2] Univ Paris 06, Sorbonne Univ, INSERM,UMR S 1136, Inst Pierre Louis Epidemiol & Sante pbl,Equipe EP, Paris, France

来源：

PEDIATRIC ALLERGY AND IMMUNOLOGY | 2014年 / 25卷 / 08期

关键词：

omalizumab; asthma; subcutaneous allergen-specific immunotherapy; IGE; COMBINATION; EFFICACY; RHINITIS; XOLAIR;

D O I：

10.1111/pai.12306

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：829 / 832

页数：4

共 13 条

[1] Xolair Is Effective in Allergics with a Low Serum IgE Level [J].

Ankerst, J. ;

Nopp, A. ;

Johansson, S. G. O. ;

Adedoyin, J. ;

Oman, H. .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2010, 152 (01) :71-74

[2]

[Anonymous], 2003, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD001186

[3]

Bethesda G. I. F., 2006, GLOB STRAT ASTHM MAN

[4] Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis [J].

Casale, TB ;

Busse, WW ;

Kline, JN ;

Ballas, ZK ;

Moss, MH ;

Townley, RG ;

Mokhtarani, M ;

Seyfert-Margolis, V ;

Asare, A ;

Bateman, K ;

Deniz, Y .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) :134-140

[5] Anti-IgE therapy: Clinical utility beyond asthma [J].

Casale, Thomas B. ;

Stokes, Jeffrey .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (04) :770-771

[6] Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge [J].

Eckman, John A. ;

Sterba, Patricia M. ;

Kelly, Denise ;

Alexander, Val ;

Liu, Mark C. ;

Bochner, Bruce S. ;

MacGlashan, Donald W., Jr. ;

Saini, Sarbjit S. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (04) :889-895

[7] Risk management in allergen immunotherapy [J].

Greineder, DK .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) :S330-S334

[8] The size of the disease relevant IgE antibody fraction in relation to 'total-IgE' predicts the efficacy of anti-IgE (Xolair®) treatment [J].

Johansson, S. G. O. ;

Nopp, A. ;

Oman, H. ;

Ankerst, J. ;

Cardell, L. O. ;

Gronneberg, R. ;

Matsols, H. ;

Rudblad, S. ;

Strand, V. ;

Stalenheim, G. .

ALLERGY, 2009, 64 (10) :1472-1477

[9] Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma [J].

Kopp, M. V. ;

Hamelmann, E. ;

Zielen, S. ;

Kamin, W. ;

Bergmann, K. -C. ;

Sieder, C. ;

Stenglein, S. ;

Seyfried, S. ;

Wahn, U. .

CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (02) :271-279

[10] Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis [J].

Kuehr, J ;

Brauburger, J ;

Zielen, S ;

Schauer, U ;

Kamin, W ;

Von Berg, A ;

Leupold, W ;

Bergmann, KC ;

Rolinck-Werninghaus, C ;

Gräve, M ;

Hultsch, T ;

Wahn, U .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (02) :274-280

← 1 2 →